CureVac N.V. (NASDAQ: CVAC) closed the day trading at $2.94 down -6.67% from the previous closing price of $3.15. In other words, the price has decreased by -$0.2100 from its previous closing price. On the day, 1282614 shares were traded.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
For a better understanding of CVAC, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.41 and its Current Ratio is at 3.56. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, SVB Securities on June 08, 2023, initiated with a Outperform rating and assigned the stock a target price of $13.
On January 19, 2023, UBS Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $8 to $18.
Jefferies Upgraded its Hold to Buy on January 09, 2023, whereas the target price for the stock was revised from $9 to $21.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CVAC now has a Market Capitalization of 661.69M and an Enterprise Value of 200.57M. For the stock, the TTM Price-to-Sale (P/S) ratio is 14.39 while its Price-to-Book (P/B) ratio in mrq is 1.03. Its current Enterprise Value per Revenue stands at 4.68 whereas that against EBITDA is -0.72.
Stock Price History:
Over the past 52 weeks, CVAC has reached a high of $12.36, while it has fallen to a 52-week low of $2.76. The 50-Day Moving Average of the stock is 3.4308, while the 200-Day Moving Average is calculated to be 6.3408.
Shares Statistics:
Over the past 3-months, CVAC traded about 818.22K shares per day on average, while over the past 10 days, CVAC traded about 791.44k shares per day. A total of 195.00M shares are outstanding, with a floating share count of 91.60M. Insiders hold about 59.08% of the company’s shares, while institutions hold 10.02% stake in the company. Shares short for CVAC as of Feb 29, 2024 were 4.39M with a Short Ratio of 5.37, compared to 4.14M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 1.96% and a Short% of Float of 11.06%.
Earnings Estimates
Current recommendations for the stock of the company come from 6 analysts. On average, analysts expect EPS of -$0.2 for the current quarter, with a high estimate of -$0.11 and a low estimate of -$0.34, while EPS last year was -$0.66. The consensus estimate for the next quarter is -$0.18, with high estimates of -$0.15 and low estimates of -$0.24.
Analysts are recommending an EPS of between -$0.9 and -$1.21 for the fiscal current year, implying an average EPS of -$1.04. EPS for the following year is -$0.99, with 9 analysts recommending between -$0.54 and -$1.42.
Revenue Estimates
7 analysts predict $36.65M in revenue for the current quarter. It ranges from a high estimate of $78.2M to a low estimate of $20.41M. As of the current estimate, CureVac N.V.’s year-ago sales were $12.83M, an estimated increase of 185.60% from the year-ago figure. For the next quarter, 3 analysts are estimating revenue of $16.3M, an increase of 12.70% less than the figure of $185.60% in the same quarter last year. There is a high estimate of $26.07M for the next quarter, whereas the lowest estimate is $8.71M.
